作者
Montserrat Rojo de la Vega, Matthew Dodson, Christine Gross, Heidi M Mansour, R Clark Lantz, Eli Chapman, Ting Wang, Stephen M Black, Joe GN Garcia, Donna D Zhang
发表日期
2016/4
来源
Current pharmacology reports
卷号
2
页码范围
91-101
出版商
Springer International Publishing
简介
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are the clinical manifestations of severe lung damage and respiratory failure. Characterized by severe inflammation and compromised lung function, ALI/ARDS result in very high mortality of affected individuals. Currently, there are no effective treatments for ALI/ARDS, and ironically, therapies intended to aid patients (specifically mechanical ventilation, MV) may aggravate the symptoms. Key events contributing to the development of ALI/ARDS are increased oxidative and proteotoxic stresses, unresolved inflammation, and compromised alveolar-capillary barrier function. Since the airways and lung tissues are constantly exposed to gaseous oxygen and airborne toxicants, the bronchial and alveolar epithelial cells are under higher oxidative stress than other tissues. Cellular protection against oxidative stress and xenobiotics is mainly …
学术搜索中的文章
MR de la Vega, M Dodson, C Gross, HM Mansour… - Current pharmacology reports, 2016